{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["23(9)"],"submitter":["Pereira MP"],"pubmed_abstract":["<h4>Background and objectives</h4>Systemic treatment of pregnant/breastfeeding atopic dermatitis (AD) patients is challenging due to limited safety data. We explored treatment practices with systemic agents, including the guideline-recommended cyclosporine as the first systemic choice as well as emerging therapies, in this vulnerable population.<h4>Patients and methods</h4>The Global Allergy and Asthma Excellence Network (GA<sup>2</sup>LEN) ADCARE initiative collected data from physicians worldwide who treat pregnant women with AD. Physicians completed an electronic questionnaire on the use of systemic agents in pregnant/breastfeeding AD patients.<h4>Results</h4>103 physicians from 32 countries completed the survey, primarily dermatologists (n = 48) or allergologists (n = 43). Antihistamin"],"journal":["Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG"],"pagination":["1116-1124"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12435135"],"repository":["biostudies-literature"],"pubmed_title":["International survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectives."],"pmcid":["PMC12435135"],"pubmed_authors":["Meesch C","Chu CY","Zuberbier T","Zhao Z","Werfel T","Ensina LF","Ozkaya E","Cork M","Katoh N","Kocaturk E","Kulthanan K","Parisi CAS","Stevanovic K","Wollenberg A","Pereira MP","Perez CR","Gregoriou S","Bruscky D","Gimenez-Arnau AM","Ramon GN","Godse K","Vakirlis E","Chong-Neto HJ","Pudasaini P","Worm M","Mitrevska NT","van Hofman I","Felix MMR","Criado RFJ","Beck LA","Gotua M","Vaswani PS","Bernstein JA","de Bruin-Weller M","Mortz CG"],"additional_accession":[]},"is_claimable":false,"name":"International survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectives.","description":"<h4>Background and objectives</h4>Systemic treatment of pregnant/breastfeeding atopic dermatitis (AD) patients is challenging due to limited safety data. We explored treatment practices with systemic agents, including the guideline-recommended cyclosporine as the first systemic choice as well as emerging therapies, in this vulnerable population.<h4>Patients and methods</h4>The Global Allergy and Asthma Excellence Network (GA<sup>2</sup>LEN) ADCARE initiative collected data from physicians worldwide who treat pregnant women with AD. Physicians completed an electronic questionnaire on the use of systemic agents in pregnant/breastfeeding AD patients.<h4>Results</h4>103 physicians from 32 countries completed the survey, primarily dermatologists (n = 48) or allergologists (n = 43). Antihistamin","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Sep","modification":"2026-04-08T19:52:31.06Z","creation":"2026-04-08T14:35:51.582Z"},"accession":"S-EPMC12435135","cross_references":{"pubmed":["40484810"],"doi":["10.1111/ddg.15728"]}}